Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.
Start price
28.05.26
/
50%
€59.40
Target price
28.05.27
€116.49
Performance (%)
41.21%
Price
24.07.26
€83.88
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr for Corcept Therapeutics Inc. has seen massive gains of 41.21%. This prediction currently runs until 28.05.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corcept Therapeutics Inc. | 5.963% | 5.963% |
| iShares Core DAX® | 0,85 % | 1,37 % |
| iShares Nasdaq 100 | -0,99 % | -3,84 % |
| iShares Nikkei 225® | -1,78 % | -8,53 % |
| iShares S&P 500 | 0,06 % | 0,61 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics (CORT) had its price target raised by Canaccord Genuity Group Inc. from $110.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.55
26.03.26
26.03.26
€95.16
26.03.27
26.03.27
150.01%
24.07.26
24.07.26
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.83
08.03.23
08.03.23
€30.31
08.03.24
08.03.24
7.94%
09.03.24
09.03.24